1. OC.08.2 THE FXR AGONIST, OBETICHOLIC ACID, INHIBITS THE CANCEROGENIC POTENTIAL OF PRIMARY HUMAN CHOLANGIOCARCINOMA CELLS: A STUDY ON PRIMARY HUMAN CELL CULTURES. Issue 2 (15th March 2018) Authors: Di Matteo, S.; Nevi, L.; Costantini, D.; Colantonio, M.; Giulitti, F.; Napoletano, C.; Safarikia, S.; Manzi, E.; Derose, A.M.; Meandro, F.; Bragazzi, M.C.; Grazi, G.; Berloco, P.B.; Giuliante, F.; Carpino, G.; Cardinale, V.; Gaudio, E.; Alvaro, D. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The cancerogenic potential of primary human Cholangioracinoma cells is inhibited by Obeticholic Acid, a Farnesoid X Receptor (FXR) agonist. Issue 1 (February 2018) Authors: Di Matteo, S.; Nevi, L.; Costantini, D.; Colantonio, M.; Giulitti, F.; Napoletano, C.; Safarikia, S.; Manzi, E.; Derose, A.M.; Melandro, F.; Bragazzi, M.C.; Grazi, G.; Berloco, P.B.; Giuliante, F.; Carpino, G.; Cardinale, V.; Gaudio, E.; Alvaro, D. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗